Beam Therapeutics (BEAM) Shares Outstanding (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Shares Outstanding data on file, last reported at $102.7 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $102.7 million, up 2.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.7 million (up 2.17% YoY), and the FY2025 annual result was $101.7 million, up 21.66% from the prior year.
• Shares Outstanding improved to $102.7 million in Q1 2026 per BEAM's latest filing, from $101.7 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $102.7 million in Q1 2026 and troughed at $69.8 million in Q1 2022.
• A 5-year average of $84.3 million and a median of $82.3 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding grew 22.77% in 2025, then grew 2.17% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $71.3 million in 2022, then advanced by 14.53% to $81.6 million in 2023, then gained by 2.45% to $83.6 million in 2024, then climbed by 21.66% to $101.7 million in 2025, then increased by 0.98% to $102.7 million in 2026.
• Business Quant data shows BEAM's Shares Outstanding at $102.7 million in Q1 2026, $101.7 million in Q4 2025, and $101.4 million in Q3 2025.